RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Receives CE Mark for ResAppDx-EU, page-574

  1. 26,625 Posts.
    lightbulb Created with Sketch. 1726
    IMO, this submission will be the next announcement, along with OSA clinical trial results, I've always said, nothing is certain in the stock market but I can't see why CE Mark won't be approved given it uses the same algorithm (different data-set but the result were as good) and clinical process as paediatric one.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.